nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abnormal factor H/FHRS proteins in sera from aHUS patients reveal novel CFH/CFHRS gene rearrangements of potential pathological relevance
|
Alba-Dominguez, Maria |
|
2012 |
217 |
11 |
p. 1134-1135 2 p. |
artikel |
2 |
Achieving efficient systemic delivery of oncolytic Vaccinia virus
|
Evgin, Laura |
|
2012 |
217 |
11 |
p. 1135- 1 p. |
artikel |
3 |
Activation of the classical complement pathway in lung cancer: A novel biomarker for diagnosis and prognosis
|
Ajona, Daniel |
|
2012 |
217 |
11 |
p. 1135- 1 p. |
artikel |
4 |
Activation of the lectin pathway of complement in pig to human xenotransplantation: Role of natural IgM
|
Bongoni, Anjan Kumar |
|
2012 |
217 |
11 |
p. 1135-1136 2 p. |
artikel |
5 |
AFFITOPE®-based vaccination against C5a alleviates disease progression in a mouse model of Alzheimer's disease
|
Landlinger, Christine |
|
2012 |
217 |
11 |
p. 1136- 1 p. |
artikel |
6 |
Allogeneic bone marrow transplantation restores complement function in human hereditary C1q deficiency
|
Olsson, Richard |
|
2012 |
217 |
11 |
p. 1136- 1 p. |
artikel |
7 |
Amyloid beta (AB) as a local regulator of complement activation?
|
Veerhuis, Robert |
|
2012 |
217 |
11 |
p. 1136-1137 2 p. |
artikel |
8 |
An alternative role of C1q in bacterial infections: Facilitating Streptococcus pneumoniae adherence and invasion of host cells
|
Agarwal, Vaibhav |
|
2012 |
217 |
11 |
p. 1137- 1 p. |
artikel |
9 |
Analysis of genes coding for CD46, CD55 and C4b-binding protein in patients with idiopathic, recurrent, spontaneous pregnancy loss
|
Mohlin, Frida C. |
|
2012 |
217 |
11 |
p. 1138- 1 p. |
artikel |
10 |
Analysis of the unique interaction of factor H with the periopathogen Treponema denticola: The paradox of factor H cleavage
|
Miller, Daniel P. |
|
2012 |
217 |
11 |
p. 1139- 1 p. |
artikel |
11 |
An engineered construct combining complement regulatory and surface recognition domains as a minimal-size functional factor H
|
Hebecker, Mario |
|
2012 |
217 |
11 |
p. 1137- 1 p. |
artikel |
12 |
A new FH autoantibody-induced murine aHUS model reveals a major protective role of decay-accelerating factor in the pathogenesis of ahus due to FH dysfunction
|
Miwa, Takashi |
|
2012 |
217 |
11 |
p. 1130-1131 2 p. |
artikel |
13 |
An ex vivo posttreatment model of sepsis: Effect on inflammation by adding complement- and CD14-inhibitors after E. coli to human whole blood
|
Egge, Kjetil H. |
|
2012 |
217 |
11 |
p. 1137-1138 2 p. |
artikel |
14 |
An IgG3 switch variant of rituximab mediates enhanced complement-dependent cytotoxicity against tumor cells with low CD20 expression levels
|
Derer, Stefanie |
|
2012 |
217 |
11 |
p. 1138- 1 p. |
artikel |
15 |
Annexin A2 and A5 serve as new ligands for C1q on apoptotic cells
|
Martin, Myriam |
|
2012 |
217 |
11 |
p. 1139- 1 p. |
artikel |
16 |
A novel assay to quantitate MASP-2/ficolin-3 complexes in serum
|
Csuka, Dorottya |
|
2012 |
217 |
11 |
p. 1131- 1 p. |
artikel |
17 |
A novel complement-mediated pathway for human TH2 induction via direct epithelial cell/T cell crosstalk
|
Fara, Antonella F. |
|
2012 |
217 |
11 |
p. 1219-1220 2 p. |
artikel |
18 |
A novel factor H-FC chimeric immunotherapeutic molecule against Neisseria gonorrhoeae
|
Shaughnessy, Jutamas |
|
2012 |
217 |
11 |
p. 1131- 1 p. |
artikel |
19 |
A novel hybrid CFHR2/CFHR5 gene develops MPGN II and provides insights into disease mechanism and therapeutic implications
|
Chen, Qian |
|
2012 |
217 |
11 |
p. 1131-1132 2 p. |
artikel |
20 |
A novel method for detection of eculizumab in complex with C5: Application in serum from a pregnant patient and her newborn child
|
Bergseth, Grethe |
|
2012 |
217 |
11 |
p. 1132- 1 p. |
artikel |
21 |
A novel non-coding mutation in C1q that causes C1q deficiency associated with recurrent infections
|
Trouw, Leendert |
|
2012 |
217 |
11 |
p. 1132- 1 p. |
artikel |
22 |
A novel role for C5a as a regulator of B1 cell biology
|
Figge, Julia |
|
2012 |
217 |
11 |
p. 1133- 1 p. |
artikel |
23 |
Antibodies against chimeric pneumococcal proteins enhance complement deposition on Streptococcus pneumoniae with different genetic backgrounds
|
Darrieux, Michelle |
|
2012 |
217 |
11 |
p. 1139- 1 p. |
artikel |
24 |
Anticomplementary activity of horse IgG and F(ab′)2 antivenoms
|
Squaiella-Baptistão, Carla Cristina |
|
2012 |
217 |
11 |
p. 1140- 1 p. |
artikel |
25 |
A possible role of MAP-1 in skeletal muscle regeneration
|
Munthe-Fog, Lea |
|
2012 |
217 |
11 |
p. 1130- 1 p. |
artikel |
26 |
A rapid and reliable method to detect homozygous CFHR1 deletion and its association with anti-factor H antibodies in atypical hemolytic uremic syndrome
|
Valoti, Elisabetta |
|
2012 |
217 |
11 |
p. 1133- 1 p. |
artikel |
27 |
A role for C1q in normal brain aging
|
Stephan, Alexander H. |
|
2012 |
217 |
11 |
p. 1133- 1 p. |
artikel |
28 |
Assay for the pattern-recognition molecule CL-L1
|
Axelgaard, Esben |
|
2012 |
217 |
11 |
p. 1140- 1 p. |
artikel |
29 |
A study of 46 atypical HUS mutations reveals that C3 and factor H mutations mirror each other on protein surfaces, engaged in the C3b–FH complex
|
Roumenina, Lubka T. |
|
2012 |
217 |
11 |
p. 1134- 1 p. |
artikel |
30 |
A user-friendly method to study the effect of FH and impact of FB variants on C3bBb convertase and C3bB proconvertase formation
|
Bettoni, Serena |
|
2012 |
217 |
11 |
p. 1134- 1 p. |
artikel |
31 |
Author Index
|
|
|
2012 |
217 |
11 |
p. I-XII nvt p. |
artikel |
32 |
Autoregulation of thromboinflammation on biomaterials and cells by a novel therapeutic coating technique
|
Teramura, Yuji |
|
2012 |
217 |
11 |
p. 1140- 1 p. |
artikel |
33 |
Beta 2-glycoprotein I derived-peptides attenuate complement-mediated intestinal damage
|
Fleming, Sherry D. |
|
2012 |
217 |
11 |
p. 1141- 1 p. |
artikel |
34 |
Binding of iC3b to human dendritic cells does not alter the cells’ phenotype and functions
|
Bajtay, Zsuzsa |
|
2012 |
217 |
11 |
p. 1141- 1 p. |
artikel |
35 |
Bride and groom in systemic inflammation – The bells ring for complement and Toll in cooperation
|
Barratt-Due, Andreas |
|
2012 |
217 |
11 |
p. 1047-1056 10 p. |
artikel |
36 |
Bringing compstatin to the next level: Novel analogs with improved potency, pharmacokinetic profiles and administration options suitable for systemic application
|
Ricklin, Daniel |
|
2012 |
217 |
11 |
p. 1141- 1 p. |
artikel |
37 |
C3a and C5a mediated signalling on pulmonary CD103+ dendritic cells is critical for their migratory function in response to influenza infection
|
Kandasamy, Matheswaran |
|
2012 |
217 |
11 |
p. 1144- 1 p. |
artikel |
38 |
C5a/C5aR interaction mediates complement activation and thrombosis on endothelial cells in atypical hemolytic uremic syndrome (aHUS)
|
Gastoldi, Sara |
|
2012 |
217 |
11 |
p. 1145-1146 2 p. |
artikel |
39 |
C5a–C5aR interaction promotes kidney infection through acting on both renal and circulating cells
|
Li, Ke |
|
2012 |
217 |
11 |
p. 1145- 1 p. |
artikel |
40 |
C5a/C5aR signaling is an important negative regulator of murine nature killer cell homeostasis and effector function
|
Li, Ke |
|
2012 |
217 |
11 |
p. 1146- 1 p. |
artikel |
41 |
C5a is a target to prevent peritoneal tissue damage in acute peritoneal injury in rats
|
Mizuno, Tomohiro |
|
2012 |
217 |
11 |
p. 1144- 1 p. |
artikel |
42 |
C5aR contributes to adipose tissue inflammation and insulin resistance
|
Phieler, Julia |
|
2012 |
217 |
11 |
p. 1146- 1 p. |
artikel |
43 |
C5aR-dependent cell activation by physiological concentrations of C5a-desArg: Insights from a novel label-free cellular assay
|
Reis, Edimara S. |
|
2012 |
217 |
11 |
p. 1147- 1 p. |
artikel |
44 |
C5aR-dependent subversion of neutrophils and dysbiotic inflammation
|
Hajishengallis, George |
|
2012 |
217 |
11 |
p. 1147-1148 2 p. |
artikel |
45 |
C5a receptor signalling in dendritic cells regulates the development of maladaptive Th2 and Th17 immune responses in experimental allergic asthma
|
Schmudde, Inken |
|
2012 |
217 |
11 |
p. 1145- 1 p. |
artikel |
46 |
C5aR regulates intestinal microbiota composition and controls the induction of gastrointestinal allergic hypersensitivity
|
Reinicke, Anna T. |
|
2012 |
217 |
11 |
p. 1147- 1 p. |
artikel |
47 |
CD46 costimulation leads to enhanced T cell activation and microrna expression
|
King, Benjamin C. |
|
2012 |
217 |
11 |
p. 1148-1149 2 p. |
artikel |
48 |
CD59 deficiency is associated with chronic hemolysis and chronic inflammatory polyradiculoneuropathy
|
Mevorach, Dror |
|
2012 |
217 |
11 |
p. 1220- 1 p. |
artikel |
49 |
CD36 is not involved in alternative pathway-mediated complement-dependent cytotoxicity on proximal tubular epithelial cells
|
Kenawy, Hany Ibrahim |
|
2012 |
217 |
11 |
p. 1148- 1 p. |
artikel |
50 |
CD20 mAb-mediated C3b deposition and complement dependent cytotoxicity of tumor cells is enhanced by blocking the action of Factor I
|
Taylor, Ronald P. |
|
2012 |
217 |
11 |
p. 1148- 1 p. |
artikel |
51 |
CFHR1 gene variants and their pathophysiological relevance
|
Tortajada, Agustin |
|
2012 |
217 |
11 |
p. 1149- 1 p. |
artikel |
52 |
CFHR5 nephropathy in a family without Cypriot ancestry
|
Medjeral-Thomas, Nicholas |
|
2012 |
217 |
11 |
p. 1149- 1 p. |
artikel |
53 |
C3-glomerulopathy associated human factor H-related proteins 2 (CFHR2) and 5 (CFHR5) regulate complement C3b and TCC
|
Eberhardt, Hannes U. |
|
2012 |
217 |
11 |
p. 1143- 1 p. |
artikel |
54 |
Characterization of a human bispecific antibody against CD20/CD55 for the treatment of burkitt lymphoma
|
Macor, Paolo |
|
2012 |
217 |
11 |
p. 1149-1150 2 p. |
artikel |
55 |
Chemotherapy of breast cancer patients induces a shift in the glycosylation pattern of plasma complement components C3 and C4
|
Oehler, Rudolf |
|
2012 |
217 |
11 |
p. 1150- 1 p. |
artikel |
56 |
C5 inhibition in mice prevents fatal C3 glomerulopathy
|
Lesher, Allison |
|
2012 |
217 |
11 |
p. 1144- 1 p. |
artikel |
57 |
C1-inhibitor efficiently inhibits Escherichia coli-induced tissue factor mRNA up-regulation, monocyte tissue factor expression and coagulation activation in human whole blood
|
Landsem, Anne |
|
2012 |
217 |
11 |
p. 1142- 1 p. |
artikel |
58 |
C1-INH rescues erythrocytes from complement mediated destruction in autoimmune hemolytic anemia
|
Wouters, Diana |
|
2012 |
217 |
11 |
p. 1142- 1 p. |
artikel |
59 |
C1 interaction with Trypanosoma cruzi calreticulin mediates ex vivo infection of human placenta
|
Castillo, Christian |
|
2012 |
217 |
11 |
p. 1141-1142 2 p. |
artikel |
60 |
Cleavage of intracellular C3 into C3a and C3b by cathepsin L is required for human TH1 induction
|
Liszewski, Kathy M. |
|
2012 |
217 |
11 |
p. 1150- 1 p. |
artikel |
61 |
Clinical analysis of peri-operative complement activation during renal ischemia-reperfusion injury following transplantation
|
Blogowski, Wojciech |
|
2012 |
217 |
11 |
p. 1150-1151 2 p. |
artikel |
62 |
CMAP: Putting complement on the map – one interaction at a time
|
Reis, Edimara S. |
|
2012 |
217 |
11 |
p. 1151- 1 p. |
artikel |
63 |
Collagen-binding MSCRAMMS of Gram-positive bacteria inhibit complement activation via the classical pathway
|
Ya-Ping, Ko |
|
2012 |
217 |
11 |
p. 1151- 1 p. |
artikel |
64 |
Collectin-11 (CL-K1):MASPs complex formation triggers activation of the complement lectin pathway—The fifth lectin pathway initiation complex
|
Ma, Ying Jie |
|
2012 |
217 |
11 |
p. 1152- 1 p. |
artikel |
65 |
Combined inhibition of complement and CD14 efficiently attenuated the inflammatory response induced by Staphylococcus aureus in a human whole blood model
|
Skjeflo, Espen |
|
2012 |
217 |
11 |
p. 1152-1153 2 p. |
artikel |
66 |
Combined inhibition of complement (C5) and CD14 markedly attenuates blood thrombogenicity, inflammation and hemodynamic changes in porcine sepsis
|
Barratt-Due, Andreas |
|
2012 |
217 |
11 |
p. 1152- 1 p. |
artikel |
67 |
Complement activation and cell activation in the Alzheimer brain
|
Stretton, Alexandra |
|
2012 |
217 |
11 |
p. 1153- 1 p. |
artikel |
68 |
Complement activation and phagocytosis in vitro of two strains of Borrelia burgdorferi S.L
|
Sandholm, Kerstin |
|
2012 |
217 |
11 |
p. 1153- 1 p. |
artikel |
69 |
Complement activation mediates placental ischemia-induced hypertension in the rat independent of vascular endothelial growth factor
|
Regal, Jean F. |
|
2012 |
217 |
11 |
p. 1153-1154 2 p. |
artikel |
70 |
Complement activity and regulation in premature, late premature and term neonates
|
Grumach, A.S. |
|
2012 |
217 |
11 |
p. 1154- 1 p. |
artikel |
71 |
Complement alternative pathway activation is associated with severity of nonalcoholic steatohepatitis
|
Segers, Filip M.E. |
|
2012 |
217 |
11 |
p. 1154- 1 p. |
artikel |
72 |
Complement alternative pathway score and broad spectrum of acquired and hereditary complement abnormalities in patients with C3 glomerulopathy
|
Le Quintrec, Moglie |
|
2012 |
217 |
11 |
p. 1155- 1 p. |
artikel |
73 |
Complement anaphylatoxin C5a supports ovarian cancer development and controls the expression of VEGF164/165 isoforms
|
Nunez-Cruz, Selene |
|
2012 |
217 |
11 |
p. 1155- 1 p. |
artikel |
74 |
Complement and antibody mediated killing of OPA-negative Neisseria gonorrhoeae by human neutrophils
|
Agarwal, Sarika |
|
2012 |
217 |
11 |
p. 1155-1156 2 p. |
artikel |
75 |
Complement and dysbiosis in periodontal disease
|
Hajishengallis, George |
|
2012 |
217 |
11 |
p. 1111-1116 6 p. |
artikel |
76 |
Complement- and platelet-mediated shuttling of blood-borne bacteria to CD8A+ dendritic cells
|
Broadley, Steven |
|
2012 |
217 |
11 |
p. 1160- 1 p. |
artikel |
77 |
Complement C5a and immune-complexes promote TNFα-dependent pathologies via stimulation of tace
|
Issuree, Priya D.A. |
|
2012 |
217 |
11 |
p. 1156- 1 p. |
artikel |
78 |
Complement C3 predicts cardiovascular event during 12 months of follow-up in haemodialysis patients and declines significantly with time on haemodialysis
|
Carter, Angela W. |
|
2012 |
217 |
11 |
p. 1156- 1 p. |
artikel |
79 |
Complement C1q production by osteoclasts and its regulation of osteoclast development
|
Teo, Boon Heng |
|
2012 |
217 |
11 |
p. 1220- 1 p. |
artikel |
80 |
Complement dependency of cholesterol crystal-induced inflammation – II. Inflammasome activation and regulation mechanisms involving reconstituted high density lipoprotein (HDL) and C-reactive protein (CRP)
|
Niyonzima, Nathalie |
|
2012 |
217 |
11 |
p. 1157- 1 p. |
artikel |
81 |
Complement dependency of cholesterol crystal-induced inflammation – I. Pathway activation mechanisms, cytokine responses and endothelial cell activation
|
Nymo, Stig |
|
2012 |
217 |
11 |
p. 1157- 1 p. |
artikel |
82 |
Complement dysregulation and disease: From genes and proteins to diagnostics and drugs
|
de Cordoba, Santiago Rodriguez |
|
2012 |
217 |
11 |
p. 1034-1046 13 p. |
artikel |
83 |
Complement in action: An analysis of patent trends from 1976 through 2011
|
DeAngelis, Robert A. |
|
2012 |
217 |
11 |
p. 1157-1158 2 p. |
artikel |
84 |
Complement inhibition is neuroprotective in a mouse model of leprosy
|
Idrissi, Nawal Bahia el |
|
2012 |
217 |
11 |
p. 1158- 1 p. |
artikel |
85 |
Complement inhibitor C4b-binding protein is involved in protein AA amyloidosis
|
Sjölander, Jonatan |
|
2012 |
217 |
11 |
p. 1158- 1 p. |
artikel |
86 |
Complement levels and complement activation in neuromyelitis optica
|
Füst, George |
|
2012 |
217 |
11 |
p. 1216- 1 p. |
artikel |
87 |
Complement mediated adverse drug effects: Prediction with complement assays and prevention with tolerance induction
|
Szebeni, Janos |
|
2012 |
217 |
11 |
p. 1158-1159 2 p. |
artikel |
88 |
Complement mediated protection against Streptococcus pneumoniae induced by PspA–PdT immunization
|
Goulart, Cibelly |
|
2012 |
217 |
11 |
p. 1159- 1 p. |
artikel |
89 |
Complement pathways in periodontitis and targeted therapeutic intervention
|
Abe, Toshiharu |
|
2012 |
217 |
11 |
p. 1159- 1 p. |
artikel |
90 |
Complement receptor C3aR modulates platelet function and thrombosis
|
Sauter, Reinhard J. |
|
2012 |
217 |
11 |
p. 1160- 1 p. |
artikel |
91 |
Complement system modulation as a target for treatment of arrhythmogenic right ventricular dysplasia/cardiomyopathy
|
Davos, Konstantinos |
|
2012 |
217 |
11 |
p. 1218- 1 p. |
artikel |
92 |
Compstatin induces allosteric changes in C3 and C3b and changes their ligand binding pattern
|
Chen, Hui |
|
2012 |
217 |
11 |
p. 1160- 1 p. |
artikel |
93 |
Consumption and dysregulation of complement classical and alternative pathways in patients with streptococcus pneumoniae-associated haemolytic uremic syndrome
|
Szilagyi, Agnes |
|
2012 |
217 |
11 |
p. 1219- 1 p. |
artikel |
94 |
Control of arthritis by local synthesis of recombinant antibody neutralizing C5
|
Macor, Paolo |
|
2012 |
217 |
11 |
p. 1160-1161 2 p. |
artikel |
95 |
C1q induces a program of gene expression in amyloid beta injured neurons necessary for neuron survival
|
Benoit, Marie E. |
|
2012 |
217 |
11 |
p. 1143- 1 p. |
artikel |
96 |
C1q negatively regulates monocyte activation by IFN-alpha derived from plasmacytoid dendritic cells
|
Li, Nan |
|
2012 |
217 |
11 |
p. 1220- 1 p. |
artikel |
97 |
C1q secreted in the tumour microenvironment promotes tumour growth in the absence of complement activation
|
Bulla, Roberta |
|
2012 |
217 |
11 |
p. 1143- 1 p. |
artikel |
98 |
CR3-bearing monocytes are protective in experimental tubulointerstitial nephritis (TIN)
|
Chaves, Lee D. |
|
2012 |
217 |
11 |
p. 1161- 1 p. |
artikel |
99 |
CR3 is the main phagocytotic receptor for iC3b opsonized particles on dendritic cells while CR4 plays supporting role
|
Sándor, Noémi |
|
2012 |
217 |
11 |
p. 1161- 1 p. |
artikel |
100 |
Critical role of C5aR signals in bone marrow-derived cells in an accelerated lupus nephritis model
|
Bao, Lihua |
|
2012 |
217 |
11 |
p. 1161-1162 2 p. |
artikel |
101 |
Crry deficiency exacerbates atherosclerosis in apoE deficient mice
|
Jayanthi, Archana |
|
2012 |
217 |
11 |
p. 1162- 1 p. |
artikel |
102 |
CSMD1 protein, a new complement inhibitor
|
Escudero-Esparza, Astrid |
|
2012 |
217 |
11 |
p. 1162- 1 p. |
artikel |
103 |
Deciphering the interactions of Streptococcus pyogenes and the complement system using a novel mouse infection model
|
Ermert, David |
|
2012 |
217 |
11 |
p. 1163- 1 p. |
artikel |
104 |
Deletion of Crry and DAF on murine platelets stimulates thrombopoiesis and increases fH-dependent resistance of peripheral platelets to complement attack
|
Barata, Lidia |
|
2012 |
217 |
11 |
p. 1163- 1 p. |
artikel |
105 |
De novo protein design of agonists and antagonists of C5a receptors
|
Monk, Peter N. |
|
2012 |
217 |
11 |
p. 1162-1163 2 p. |
artikel |
106 |
Determinants of the substrate specificity of the complement initiating protease, C1r
|
Wijeyewickrema, Lakshmi C. |
|
2012 |
217 |
11 |
p. 1163-1164 2 p. |
artikel |
107 |
Developmental abnormalities in Masp1/3-deficient mice
|
Takahashi, Minoru |
|
2012 |
217 |
11 |
p. 1164- 1 p. |
artikel |
108 |
Development of an anti-C5/C5a antibody therapeutic that inhibits inflammatory responses via C5aR and C5L2 while maintaining MAC-dependent bactericidal functions
|
An, Ling-Ling |
|
2012 |
217 |
11 |
p. 1219- 1 p. |
artikel |
109 |
Development of humanized complement factor H transgenic mice to interrogate the effect of age-related macular degeneration risk associated variants in vivo
|
Kelly, Una |
|
2012 |
217 |
11 |
p. 1164- 1 p. |
artikel |
110 |
Distinct roles of the complement C5a receptors C5aR and C5L2 in bacterial and bacterial component-induced inflammation in human whole blood
|
An, Ling-Ling |
|
2012 |
217 |
11 |
p. 1164-1165 2 p. |
artikel |
111 |
Does Salmonella lipopolysaccharides with sialic acid inhibit C3 activation?
|
Futoma-Koloch, Bozena |
|
2012 |
217 |
11 |
p. 1165- 1 p. |
artikel |
112 |
Editorial Board
|
|
|
2012 |
217 |
11 |
p. CO2- 1 p. |
artikel |
113 |
Effect of regulation of glycolysis on tumor inflammation and immune status
|
Inoue, Norimitsu |
|
2012 |
217 |
11 |
p. 1165- 1 p. |
artikel |
114 |
Effects of C1 esterase inhibitor on attenuation of ischemia/reperfusion injury in a rat hind limb model
|
Dührkop-Sisewitsch, Claudia |
|
2012 |
217 |
11 |
p. 1165-1166 2 p. |
artikel |
115 |
Effects of MASP-1 on blood coagulation studied by thrombelastometry
|
Aeschliman, Judith |
|
2012 |
217 |
11 |
p. 1166- 1 p. |
artikel |
116 |
Electron microscopy reveals coexistence of distinct conformations of iC3b
|
Alcorlo, Martin |
|
2012 |
217 |
11 |
p. 1166- 1 p. |
artikel |
117 |
Endogenous and natural complement inhibitor attenuates myocardial injury and arterial thrombogenesis
|
Skjoedt, Mikkel-Ole |
|
2012 |
217 |
11 |
p. 1166-1167 2 p. |
artikel |
118 |
Endothelial cells injured by the thrombotic microangiopathy-inducing drug cyclosporin release complement-activating microparticles
|
Renner, Brandon |
|
2012 |
217 |
11 |
p. 1167- 1 p. |
artikel |
119 |
Enzymatic properties of the MASP-3 serine protease domain and crystal structure of its complex with ecotin
|
Gaboriaud, Christine |
|
2012 |
217 |
11 |
p. 1167- 1 p. |
artikel |
120 |
Escherichia coli-induced coagulation activation and pentraxin 3 release is highly dependent on complement and CD14
|
Brekke, Ole L. |
|
2012 |
217 |
11 |
p. 1167-1168 2 p. |
artikel |
121 |
Essential role of surface-bound complement factor H in controlling immune complex-induced arthritis
|
Banda, Nirmal K. |
|
2012 |
217 |
11 |
p. 1168- 1 p. |
artikel |
122 |
Evidence of classical complement activation during blood–biomaterial interaction in LDL apheresis
|
Ludviksen, Judith Krey A. |
|
2012 |
217 |
11 |
p. 1168- 1 p. |
artikel |
123 |
Evolution of the thioester-containing protein genes in the arthropoda
|
Sekiguchi, Reo |
|
2012 |
217 |
11 |
p. 1168-1169 2 p. |
artikel |
124 |
Expression of complement factors and functional C5a receptors in human embryonic stem cells, and induced pluripotent stem cells
|
Hawksworth, Owen A. |
|
2012 |
217 |
11 |
p. 1169- 1 p. |
artikel |
125 |
Expression of the complement system is upregulated in subcutaneous adipocytes from non-obese hypertriglyceridemic subjects and is associated with local insulin resistance
|
Van Greevenbroek, Marleen M.J. |
|
2012 |
217 |
11 |
p. 1169- 1 p. |
artikel |
126 |
Extracellular adherence protein (Eap) of Staphylococcus aureus evades innate immunity by inhibiting complement activation and neutrophil elastase
|
Stapels, Daphne A.C. |
|
2012 |
217 |
11 |
p. 1170- 1 p. |
artikel |
127 |
Factor H-dependent regulation of the alternative pathway of complement by Meningococci that lack FHBP, NSPA, capsule and lipooligosaccharide sialic acid
|
Lewis, Lisa A. |
|
2012 |
217 |
11 |
p. 1170- 1 p. |
artikel |
128 |
Factor XII missense mutation THR328LYS in three Brazilian families
|
Cordeiro, Elisabete |
|
2012 |
217 |
11 |
p. 1170-1171 2 p. |
artikel |
129 |
Familial membranoproliferative glomerulonephritis type I associated with a functionally significant mutation in complement factor H
|
Wong, Edwin |
|
2012 |
217 |
11 |
p. 1171- 1 p. |
artikel |
130 |
Ficolin-2 properties differ between serum and plasma
|
Hein, Estrid |
|
2012 |
217 |
11 |
p. 1171- 1 p. |
artikel |
131 |
Formation of an immune complex resembling C5b-9 via coagulation factors and platelets
|
Gorham Jr., Ronald D. |
|
2012 |
217 |
11 |
p. 1171-1172 2 p. |
artikel |
132 |
Free heme transforms endothelial cells into alternative pathway activators. Implications for the hemolytic and uremic syndrome
|
Frimat, Marie |
|
2012 |
217 |
11 |
p. 1172- 1 p. |
artikel |
133 |
Functional analyses of complement convertases using C3 and C5-depleted sera
|
Okroj, Marcin |
|
2012 |
217 |
11 |
p. 1221-1222 2 p. |
artikel |
134 |
Functional analysis of the complement system in oligoarticular juvenile idiopathic arthritis
|
Brunner, Juergen K.H. |
|
2012 |
217 |
11 |
p. 1172- 1 p. |
artikel |
135 |
Functional C1-inhibitor level increases during attacks of hereditary angioedema
|
Varga, Lilian A. |
|
2012 |
217 |
11 |
p. 1172-1173 2 p. |
artikel |
136 |
Galactosylated IgG1 immune complexes diminish C5a-dependent inflammation in experimental Epidermolysis Bullosa Acquisita
|
Kilchenstein, Regina |
|
2012 |
217 |
11 |
p. 1129-1130 2 p. |
artikel |
137 |
GAPDH exposed on human and pneumococcal cell surface is a novel C1q ligand
|
Tacnet-Delorme, Pascale |
|
2012 |
217 |
11 |
p. 1173- 1 p. |
artikel |
138 |
Global gene expression analysis of the effects of sublytic complement on CT26 colon carcinoma cells using microarray technology
|
Towner, Laurence D. |
|
2012 |
217 |
11 |
p. 1173- 1 p. |
artikel |
139 |
Higher levels of complement C3a (activated C3) are cross-sectionally associated with higher carotid media thickness and lower ankle-arm blood pressure index: The CODAM study
|
Hertle, Elisabeth |
|
2012 |
217 |
11 |
p. 1174- 1 p. |
artikel |
140 |
High performance fluid-based array using protein AG for coupling antibodies to carboxylated microspheres for quantification of 10 complement protein components
|
Nascimento, Eduardo J.M. |
|
2012 |
217 |
11 |
p. 1173-1174 2 p. |
artikel |
141 |
How does degradation of neutrophil extracellular traps correlate with the activity of systemic lupus erythematosus?
|
Leffler, Jonatan |
|
2012 |
217 |
11 |
p. 1174- 1 p. |
artikel |
142 |
Human CR1 as a target for selective treatment of autoimmune and allergic diseases in humanised SCID mice
|
Tchorbanov, Andrey I. |
|
2012 |
217 |
11 |
p. 1174-1175 2 p. |
artikel |
143 |
Hunting for biomarkers: The complement system in Alzheimer's disease
|
Hakobyan, Svetlana |
|
2012 |
217 |
11 |
p. 1175- 1 p. |
artikel |
144 |
Identification of a novel C5a-inhibiting human and mouse-specific Spiegelmer® for treatment of septic shock and its proof of concept in the CLP mouse model
|
Vater, Axel |
|
2012 |
217 |
11 |
p. 1175- 1 p. |
artikel |
145 |
Identification of a novel mode of complement activation on stimulated platelets mediated by properdin
|
Saggu, Gurpanna |
|
2012 |
217 |
11 |
p. 1175-1176 2 p. |
artikel |
146 |
Identification of critical core amino acids of a major linear C1q epitope recognized by SLE auto-antibodies
|
Vanhecke, Dominique |
|
2012 |
217 |
11 |
p. 1176- 1 p. |
artikel |
147 |
Identification of Jagged1 as a novel ligand for CD46: An interaction required for normal induction and regulation of human TH1 responses
|
Le Friec, Gaelle |
|
2012 |
217 |
11 |
p. 1176- 1 p. |
artikel |
148 |
Identification of the gC1qR binding sites for HIV-1 gp41 and HCV core protein
|
Pednekar, Lina |
|
2012 |
217 |
11 |
p. 1177- 1 p. |
artikel |
149 |
IgG2a immune complexes enhance C5a-mediated inflammation
|
Wagner, Marina |
|
2012 |
217 |
11 |
p. 1177- 1 p. |
artikel |
150 |
IgM-mediated enhancement of immune responses
|
Ding, Zhoujie |
|
2012 |
217 |
11 |
p. 1177-1178 2 p. |
artikel |
151 |
Immune evasion in leptospira: The secretion of metalloproteases that directly cleave complement proteins
|
Fraga, Tatiana R. |
|
2012 |
217 |
11 |
p. 1178- 1 p. |
artikel |
152 |
Inhibition of ABO incompatibility using a novel small peptide
|
Sharp, Julia A. |
|
2012 |
217 |
11 |
p. 1178-1179 2 p. |
artikel |
153 |
Inhibition of biomaterial-induced complement activation attenuates the inflammatory host response to implantation
|
Kourtzelis, Ioannis |
|
2012 |
217 |
11 |
p. 1179- 1 p. |
artikel |
154 |
Inhibition of complement-dependent cytotoxicity by C9-binding cellular stress proteins
|
Rozenberg, Perri |
|
2012 |
217 |
11 |
p. 1179- 1 p. |
artikel |
155 |
Interactions of the complement system with molecules of extracellular matrix: Relevance for joint diseases
|
Happonen, Kaisa E. |
|
2012 |
217 |
11 |
p. 1088-1096 9 p. |
artikel |
156 |
Interactions of the humoral pattern recognition molecule PTX3 with the complement system
|
Doni, Andrea |
|
2012 |
217 |
11 |
p. 1122-1128 7 p. |
artikel |
157 |
Investigation of complement activation by neutral liposomes
|
Klapper, Yvonne |
|
2012 |
217 |
11 |
p. 1179-1180 2 p. |
artikel |
158 |
In vivo dissection of the contribution of fB, fD and properdin to alternative pathway activation on membranes
|
Wu, Xiaobo |
|
2012 |
217 |
11 |
p. 1178- 1 p. |
artikel |
159 |
Involvement of the murine epididymal C4BP in the reproductive system but not in the complement system
|
Nonaka, Mayumi I. |
|
2012 |
217 |
11 |
p. 1180- 1 p. |
artikel |
160 |
Knockdown of the membrane regulators CD46, CD55, CD59 by sirna enhances complement- and macrophage-dependent anti-tumor effects of rituximab and Campath-1H
|
Mamidi, Srinivas |
|
2012 |
217 |
11 |
p. 1180- 1 p. |
artikel |
161 |
Large-scale generation of IgG-depleted human complement source for functional bacterial immunoassays
|
Brookes, Charlotte |
|
2012 |
217 |
11 |
p. 1181- 1 p. |
artikel |
162 |
Large spectrum of Factor B aHUS mutations functional consequences on the C3 convertase – From gain to lack of functional consequence
|
Roumenina, Lubka T. |
|
2012 |
217 |
11 |
p. 1180-1181 2 p. |
artikel |
163 |
Leptospiral immunoglobulin-like proteins interact with plasminogen to escape complement mediated-killing
|
Valencia, Mónica M.C. |
|
2012 |
217 |
11 |
p. 1181- 1 p. |
artikel |
164 |
Ligand-induced dimerisation of the complement C5aR and C5L2 receptors by C5a but not C5a-des Arg
|
Croker, Daniel E. |
|
2012 |
217 |
11 |
p. 1181-1182 2 p. |
artikel |
165 |
LJM19, a salivary protein from the sand fly vector that transmits leishmaniasis, is a novel inhibitor of the classical pathway of complement
|
Ferreira, Viviana P. |
|
2012 |
217 |
11 |
p. 1182- 1 p. |
artikel |
166 |
Local and not systemic factor H production dictates risk of age-related macular degeneration in liver transplant recipients
|
Khandhadia, Sam |
|
2012 |
217 |
11 |
p. 1182-1183 2 p. |
artikel |
167 |
Localised inhibition of coagulation limits acute complement mediated damage in high risk renal transplantation
|
Karegli, Julieta |
|
2012 |
217 |
11 |
p. 1183- 1 p. |
artikel |
168 |
Low levels of mannan-binding lectin or ficolins are not associated with an increased risk of cytomegalovirus disease in HIV-infected patients – A case–control study nested within the Swiss HIV Cohort Study
|
Egli, Adrian |
|
2012 |
217 |
11 |
p. 1183- 1 p. |
artikel |
169 |
Maggot excretions and secretions reduce complement activation
|
Cazander, Gwendolyn |
|
2012 |
217 |
11 |
p. 1184- 1 p. |
artikel |
170 |
Manipulating the mediator: Modulation of the alternative complement pathway C3 convertase in health, disease and therapy
|
Ricklin, Daniel |
|
2012 |
217 |
11 |
p. 1057-1066 10 p. |
artikel |
171 |
Mannan-binding lectin associated serine protease-3 is a novel predictor of overall survival in patients with metastatic renal cell carcinoma
|
Jensenius, Jens C. |
|
2012 |
217 |
11 |
p. 1184- 1 p. |
artikel |
172 |
Mannan-binding lectin in pregnancy: Analysis of serum concentrations/genotypes with regard to clinical data in 212 women
|
Potlukova, Eliska |
|
2012 |
217 |
11 |
p. 1184-1185 2 p. |
artikel |
173 |
Mannose-binding lectin and lectin pathway in subarachnoid hemorrhage patients
|
Zangari, Rosalia |
|
2012 |
217 |
11 |
p. 1185- 1 p. |
artikel |
174 |
Mannose-binding lectin deficiency reduces functional deficits and histological damage after experimental traumatic brain injury
|
Longhi, Luca |
|
2012 |
217 |
11 |
p. 1185- 1 p. |
artikel |
175 |
MASP-1 is crucial for lectin pathway activation in human serum, while neither MASP-1 nor MASP-3 are required for alternative pathway function
|
Degn, Soren E. |
|
2012 |
217 |
11 |
p. 1218-1219 2 p. |
artikel |
176 |
MASP levels in cardio- and cerebrovascular diseases: A pilot study
|
Frauenknecht, Vera |
|
2012 |
217 |
11 |
p. 1186- 1 p. |
artikel |
177 |
MBL-associated serine protease (MASP)-1/3 promotes the initiation of the alternative pathway activation
|
Kodama, Toshihisa |
|
2012 |
217 |
11 |
p. 1186- 1 p. |
artikel |
178 |
MBL/ficolin associated protein-1 inhibits the complex formation between MASPs and MBL
|
Rosbjerg, Anne |
|
2012 |
217 |
11 |
p. 1186- 1 p. |
artikel |
179 |
MCP (CD46) autoantibodies are associated with atypical hemolytic uremic syndrome
|
Bennaceur, Karim |
|
2012 |
217 |
11 |
p. 1187- 1 p. |
artikel |
180 |
Membrane attack complex deposition on gram-positive bacteria
|
Berends, Evelien T.M. |
|
2012 |
217 |
11 |
p. 1187- 1 p. |
artikel |
181 |
Membrane cofactor protein (MCP) haplotype, which predisposes to atypical hemolytic and uremic syndrome, has no consequence on neutrophils and endothelial cells MCP levels or on HUVECs ability to activate complement
|
frimat, Marie |
|
2012 |
217 |
11 |
p. 1187-1188 2 p. |
artikel |
182 |
M-ficolin binds specifically to two capsulare structures of Streptococcus pneumoniae
|
Kjaer, Troels |
|
2012 |
217 |
11 |
p. 1183-1184 2 p. |
artikel |
183 |
Microbial pathogens of diverse origin inhibit the terminal complement pathway: A common immune evasion strategy?
|
Hallström, Teresia |
|
2012 |
217 |
11 |
p. 1188- 1 p. |
artikel |
184 |
Modulation of human T cell function by exogenous and endogenous C3
|
Erdei, Anna |
|
2012 |
217 |
11 |
p. 1188- 1 p. |
artikel |
185 |
Molecular and functional characterization of the interaction of L-ficolin with Streptococcus pneumoniae
|
Stermann, Emilie |
|
2012 |
217 |
11 |
p. 1188-1189 2 p. |
artikel |
186 |
Natural inhibitors of the lectin pathway
|
Paréj, Katalin |
|
2012 |
217 |
11 |
p. 1189- 1 p. |
artikel |
187 |
Negative regulation of human nature killer cells by complement
|
Min, Xiaoyun |
|
2012 |
217 |
11 |
p. 1189- 1 p. |
artikel |
188 |
Negative regulation of NK cell function through engagement of CR3 with its complement ligand
|
Li, Ke |
|
2012 |
217 |
11 |
p. 1189-1190 2 p. |
artikel |
189 |
New crossroads between complement and apoptosis after trauma
|
Huber-Lang, Markus S. |
|
2012 |
217 |
11 |
p. 1190- 1 p. |
artikel |
190 |
New insights into the inhibitory function of CR1 on human B lymphocytes; the functional consequences of the crosstalk between BCR, TLR9 and CR1
|
Kremlitzka, Mariann |
|
2012 |
217 |
11 |
p. 1190- 1 p. |
artikel |
191 |
NGR conjugated pegylated polymeric nanoparticles for targeted delivery of docetaxel
|
Gupta, Madhu |
|
2012 |
217 |
11 |
p. 1190-1191 2 p. |
artikel |
192 |
Non-proteolytically activated C3 promotes binding of activated platelets and platelet-derived microparticles to leukocytes via CD11b/CD18
|
Hamad, Osama A. |
|
2012 |
217 |
11 |
p. 1191- 1 p. |
artikel |
193 |
Novel monoclonal antibodies to C3d that target and identify in living animals sites of complement activation
|
Thurman, Joshua M. |
|
2012 |
217 |
11 |
p. 1191- 1 p. |
artikel |
194 |
Novel mouse anti-mouse monoclonal antibodies that block either the ligand or receptor member of the CR2–C3d interaction pair impair antigen-specific humoral immune responses to model antigens
|
Kulik, Liudmila |
|
2012 |
217 |
11 |
p. 1192- 1 p. |
artikel |
195 |
Omeros_Advertisement
|
|
|
2012 |
217 |
11 |
p. XIII- 1 p. |
artikel |
196 |
On the conformational flexibility of C3b: A molecular insight into activation and transformation of a major complement effector
|
Gipson, Bryant |
|
2012 |
217 |
11 |
p. 1192- 1 p. |
artikel |
197 |
Paroxysmal nocturnal hemoglobinuria and other complement-mediated hematological disorders
|
Risitano, Antonio M. |
|
2012 |
217 |
11 |
p. 1080-1087 8 p. |
artikel |
198 |
Peptide and protein inhibitors targeting the C3 convertase efficiently prevent surface C3 deposition and subsequent hemolysis of paroxysmal nocturnal hemoglobinuria (PNH) erythrocytes
|
Risitano, Antonio M. |
|
2012 |
217 |
11 |
p. 1217- 1 p. |
artikel |
199 |
Peripheral gangrenes in children with atypical hemolytic uremic syndrome
|
Malina, Michal |
|
2012 |
217 |
11 |
p. 1192-1193 2 p. |
artikel |
200 |
Phagocytosis of Escherichia coli in human whole blood: Early complement dependency is succeeded by late CD14 dependency over time
|
Christansen, Dorte |
|
2012 |
217 |
11 |
p. 1193- 1 p. |
artikel |
201 |
Pinpointing the time and cause of fetal demise in the Crry−/− embryo
|
Triebwasser, Michael P. |
|
2012 |
217 |
11 |
p. 1193- 1 p. |
artikel |
202 |
Poly-cation containing alginate microcapsules induce cytokines by a complement-dependent mechanism
|
Rokstad, Anne Mari |
|
2012 |
217 |
11 |
p. 1221- 1 p. |
artikel |
203 |
Preface
|
Lambris, John D. |
|
2012 |
217 |
11 |
p. 1025- 1 p. |
artikel |
204 |
Premolis semirufa envenomation, disease affecting rubber tappers of the Amazon: Searching for caterpillar-bristles toxic components acting on the complement system
|
Boas, Isadora Maria Villas |
|
2012 |
217 |
11 |
p. 1194- 1 p. |
artikel |
205 |
Pre-transplant ficolin-3 levels are associated with kidney allograft survival
|
Bay, Jakob T. |
|
2012 |
217 |
11 |
p. 1193-1194 2 p. |
artikel |
206 |
Production of functional full-length recombinant human C1q
|
Bally, Isabelle |
|
2012 |
217 |
11 |
p. 1194- 1 p. |
artikel |
207 |
Prolonged voltage-gated calcium channel activation by sublytic complement activation in retinal pigment epithelium, a mechanism for controlling VEGF secretion
|
Rohrer, Bärbel |
|
2012 |
217 |
11 |
p. 1194-1195 2 p. |
artikel |
208 |
Properdin and complement amplification loop in the pathogenesis of experimental autoimmune myasthenia gravis (EAMG)
|
Soltys, Jindrich |
|
2012 |
217 |
11 |
p. 1195- 1 p. |
artikel |
209 |
Properdin binding to the surface of leptospira promotes complement activation and controls proliferation of non-pathogenic bacteria in vitro
|
Martínez, Adriana G.P. |
|
2012 |
217 |
11 |
p. 1195- 1 p. |
artikel |
210 |
Properdin deficiency exacerbates C3 glomerulopathy in factor H-deficient mice
|
Ruseva, Marieta M. |
|
2012 |
217 |
11 |
p. 1196- 1 p. |
artikel |
211 |
Properdin is increased after allergen challenge of asthmatic patients and contributes to OVA-induced airway inflammation and AHR at the effector phase by enhancing C3a generation in mice
|
Wang, Yuan |
|
2012 |
217 |
11 |
p. 1196- 1 p. |
artikel |
212 |
Purification and biochemical characterization of functional complement factor H from human plasma fractions
|
Brandstätter, Hubert |
|
2012 |
217 |
11 |
p. 1196- 1 p. |
artikel |
213 |
Putting the structure into complement
|
Lea, Susan M. |
|
2012 |
217 |
11 |
p. 1117-1121 5 p. |
artikel |
214 |
Rat adipose tissue-derived stromal cells in a low serum medium attenuate peritoneal injuries in rat zymosan-induced peritonitis
|
Kim, Hangsoo |
|
2012 |
217 |
11 |
p. 1197- 1 p. |
artikel |
215 |
Rational engineering of a novel complement regulator-based therapeutic affords triple targeting of host surfaces and pathway-specific inhibition of complement activation
|
Schmidt, Christoph Q. |
|
2012 |
217 |
11 |
p. 1197- 1 p. |
artikel |
216 |
Recombinant anti-human and anti-porcine CD14 antibodies
|
Lau, Corinna |
|
2012 |
217 |
11 |
p. 1197-1198 2 p. |
artikel |
217 |
Recombinant mouse factor H from Pichia pastoris
|
Kerr, Heather |
|
2012 |
217 |
11 |
p. 1198- 1 p. |
artikel |
218 |
Reduced activity of the lectin complement pathway in cystic fibrosis
|
Keizer, Sandrino M.P.D. |
|
2012 |
217 |
11 |
p. 1198- 1 p. |
artikel |
219 |
Reduction of complement regulator CD59 expression on human kidney cells by Shiga toxin 2
|
Ehrlenbach, Silvia |
|
2012 |
217 |
11 |
p. 1198-1199 2 p. |
artikel |
220 |
Regulation of complement in whole blood by heparin molecularly imprinted polymer particles
|
Huang, Shan |
|
2012 |
217 |
11 |
p. 1199- 1 p. |
artikel |
221 |
Response gene to complement-32 is a potential biomarker of relapses in multiple sclerosis
|
Rus, Horea |
|
2012 |
217 |
11 |
p. 1199- 1 p. |
artikel |
222 |
Robust measurement of rat complement system activation with novel ELISA-based assays
|
Kotimaa, Juha P. |
|
2012 |
217 |
11 |
p. 1199-1200 2 p. |
artikel |
223 |
Role of complement in a murine model of peanut-induced anaphylaxis
|
Kodama, Toshihisa |
|
2012 |
217 |
11 |
p. 1200- 1 p. |
artikel |
224 |
Role of complement in modulation of TH2 response in prostate cancer cells
|
Yamamoto, Hidekazu |
|
2012 |
217 |
11 |
p. 1200- 1 p. |
artikel |
225 |
Role of complement in the early stages of viral infections
|
Langlois, Marie-Pierre |
|
2012 |
217 |
11 |
p. 1200-1201 2 p. |
artikel |
226 |
Role of properdin in systemic AP complement consumption caused by Crry deficiency
|
Lesher, Allison |
|
2012 |
217 |
11 |
p. 1201- 1 p. |
artikel |
227 |
Role of the alternative pathway of complement in ischemia/reperfusion and chronic graft injury in a mouse model of kidney allograft
|
Cavinato, Regiane Aparecida |
|
2012 |
217 |
11 |
p. 1201- 1 p. |
artikel |
228 |
Saliva activates the complement system
|
Gunput, Sabrina T.G. |
|
2012 |
217 |
11 |
p. 1201-1202 2 p. |
artikel |
229 |
Screening patients with inherited GPI anchor deficiency to establish concept of the new disease
|
Murakami, Yoshiko |
|
2012 |
217 |
11 |
p. 1202- 1 p. |
artikel |
230 |
Serological analysis of complement in patients with neuromyelitis optica
|
Nytrova, Petra |
|
2012 |
217 |
11 |
p. 1202- 1 p. |
artikel |
231 |
Signals through CR3 generate alternatively activated macrophages (AAMs) which are protective in complement-dependent glomerulonephritis (GN)
|
Alexander, Jessy J. |
|
2012 |
217 |
11 |
p. 1203- 1 p. |
artikel |
232 |
Silencing of mortalin, a regulator of the complement membrane attack complex, as anticancer adjuvant therapy
|
Donin, Natalie |
|
2012 |
217 |
11 |
p. 1203- 1 p. |
artikel |
233 |
Species selectivity in poxviral complement regulators is dictated primarily by the charge reversal in the central complement control protein modules
|
Yadav, Nand Viveka |
|
2012 |
217 |
11 |
p. 1217- 1 p. |
artikel |
234 |
Specificity and mechanism of assembly of C4b binding protein
|
Caesar, Joseph J.E. |
|
2012 |
217 |
11 |
p. 1204- 1 p. |
artikel |
235 |
Specific serum immunoglobulin recognizing staphylococcal wall teichoic acid induces complement-mediated opsonophagocytosis against Staphylococcus aureus
|
Lee, Bok L. |
|
2012 |
217 |
11 |
p. 1203- 1 p. |
artikel |
236 |
Staphylococcal proteases aid evasion of human complement system
|
Jusko, Monika |
|
2012 |
217 |
11 |
p. 1204- 1 p. |
artikel |
237 |
Staphylococcus aureus surface protein SdrE binds the complement regulator factor H to evade the immune response
|
Sharp, Julia A. |
|
2012 |
217 |
11 |
p. 1204- 1 p. |
artikel |
238 |
Structural basis for activation of the complement system by C4 cleavage
|
Andersen, Gregers R. |
|
2012 |
217 |
11 |
p. 1205- 1 p. |
artikel |
239 |
Structural characterization of the N-terminal region of Streptococcus pneumonia surface protein C
|
Herbert, Andrew P. |
|
2012 |
217 |
11 |
p. 1205- 1 p. |
artikel |
240 |
Structural comparison of the C-terminal domains of factor H and CFHR-1 suggests explanation for the location of a major autoantibody epitope in autoimmune aHUS
|
Bhattacharjee, Arnab |
|
2012 |
217 |
11 |
p. 1221- 1 p. |
artikel |
241 |
Structural findings in complement factor H-related proteins unravel the pathogenesis of C3 glomerulopathy
|
de Jorge, Elena Goicoechea |
|
2012 |
217 |
11 |
p. 1205- 1 p. |
artikel |
242 |
Survival of bacterial blood isolates in serum or blood can be impaired with factor H fragment CFH5–7
|
Haapasalo-Tuomainen, Karita |
|
2012 |
217 |
11 |
p. 1205-1206 2 p. |
artikel |
243 |
Synchronized transcription of the three C1q genes in dendritic cells – Molecular and chromosomal mechanisms
|
Tan, Carol Shurong |
|
2012 |
217 |
11 |
p. 1206- 1 p. |
artikel |
244 |
Systemic CD14-inhibition attenuates local inflammatory responses organ-dependently in porcine Escherichia coli-sepsis
|
Thorgersen, Ebbe Billmann |
|
2012 |
217 |
11 |
p. 1206- 1 p. |
artikel |
245 |
Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysis
|
DeAngelis, Robert A. |
|
2012 |
217 |
11 |
p. 1097-1105 9 p. |
artikel |
246 |
Targeted deep sequencing of the complement system in complementopathies
|
Triebwasser, Michael P. |
|
2012 |
217 |
11 |
p. 1206-1207 2 p. |
artikel |
247 |
Targeted silencing of mCRP (CD46, CD55, CD59) by siRNA encapsulated in transferrin-liposomes specifically sensitizes cancer cells to complement attack
|
Mamidi, Srinivas |
|
2012 |
217 |
11 |
p. 1207- 1 p. |
artikel |
248 |
Targeting MBL in cerebral ischemia induces long lasting protection with a wide therapeutic window
|
Orsini, Franca |
|
2012 |
217 |
11 |
p. 1207- 1 p. |
artikel |
249 |
Targeting the glomerular basement membrane to control unwanted complement activation
|
Hunze, Eva-Maria |
|
2012 |
217 |
11 |
p. 1208- 1 p. |
artikel |
250 |
Terminal complement pathway therapy in experimental traumatic brain injury
|
Ramaglia, Valeria |
|
2012 |
217 |
11 |
p. 1208- 1 p. |
artikel |
251 |
The C3a receptor mediates protection from intestinal ischemia reperfusion injuries by impairing neutrophil mobilization
|
Woodruff, Trent M. |
|
2012 |
217 |
11 |
p. 1209- 1 p. |
artikel |
252 |
The complement anaphylatoxin C3a is critical in generating both innate and adaptive immune responses to Listeria monocytogenes due to its indispensible role in immune cell survival
|
Mueller-Ortiz, Stacey L. |
|
2012 |
217 |
11 |
p. 1209- 1 p. |
artikel |
253 |
The complement anaphylatoxin C3a receptor (C3aR) contributes to the inflammatory response in acute dextran sulphate sodium (DSS)-induced colitis in mice
|
Klos, Andreas |
|
2012 |
217 |
11 |
p. 1209-1210 2 p. |
artikel |
254 |
The complement system in ischemia–reperfusion injuries
|
Gorsuch, William B. |
|
2012 |
217 |
11 |
p. 1026-1033 8 p. |
artikel |
255 |
The C-type lectin of the aggrecan G3 domain activates complement
|
Fürst, Camilla Melin |
|
2012 |
217 |
11 |
p. 1208- 1 p. |
artikel |
256 |
The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer models and acts by CR2-dependent targeting of CR1 regulatory activity
|
Holers, Michael |
|
2012 |
217 |
11 |
p. 1210- 1 p. |
artikel |
257 |
The immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases
|
Karsten, Christian M. |
|
2012 |
217 |
11 |
p. 1067-1079 13 p. |
artikel |
258 |
The interference of genetic background of C57Bl/6 and A/J mice on the development of acute and chronic inflammatory response induced by ethanol: Possible contribution of C5
|
Bavia, Lorena |
|
2012 |
217 |
11 |
p. 1210- 1 p. |
artikel |
259 |
The lectin pathway triggered by activated platelets
|
Kozarcanin, Huda |
|
2012 |
217 |
11 |
p. 1130- 1 p. |
artikel |
260 |
The novel Jagged1/CD46 interaction: A prime target for immune modulation by viruses?
|
Sheppard, Devon |
|
2012 |
217 |
11 |
p. 1210-1211 2 p. |
artikel |
261 |
Therapeutic application of recombinant properdin confers a significant degree of protection during Neisseria meningitidis infection
|
Ali, Youssif M. |
|
2012 |
217 |
11 |
p. 1214- 1 p. |
artikel |
262 |
The ratio between C4 and C4BP adsorbed from plasma predicts cytokine generation induced by artificial polymers in contact with whole blood
|
Engberg, Anna E. |
|
2012 |
217 |
11 |
p. 1211- 1 p. |
artikel |
263 |
The role of complement in bone healing: Fracture healing in C3 and C5-deficient mice
|
Ehrnthaller, Christian M. |
|
2012 |
217 |
11 |
p. 1211- 1 p. |
artikel |
264 |
The role of properdin in zymosan- and Escherichia coli-induced complement activation
|
Harboe, Morten |
|
2012 |
217 |
11 |
p. 1212- 1 p. |
artikel |
265 |
The role of the complement pathway in neuronal migration in the developing brain
|
Gorelik, Anna |
|
2012 |
217 |
11 |
p. 1212- 1 p. |
artikel |
266 |
The roles of the C5a receptor on the human erythroleukaemia K562 cells during the hemin-induced erythropoiesis
|
Nishiura, Hiroshi |
|
2012 |
217 |
11 |
p. 1217- 1 p. |
artikel |
267 |
The salivary scavenger and agglutinin (SALSA) binds MBL and regulates the lectin pathway of complement in solution and on surfaces
|
Reichhardt, Martin P. |
|
2012 |
217 |
11 |
p. 1212- 1 p. |
artikel |
268 |
The surface binding region of complement Factor H guides the staphylococcal Efb to cell surfaces to allow local complement inhibition
|
Boehm, Sascha |
|
2012 |
217 |
11 |
p. 1213- 1 p. |
artikel |
269 |
The systemic inflammatory reaction in polymicrobial sepsis induced by murine cecal ligation and puncture is equally dependent on C5 and CD14
|
Mollnes, Tom E. |
|
2012 |
217 |
11 |
p. 1129- 1 p. |
artikel |
270 |
The tick-over theory revisited: Is C3 a contact-activated protein?
|
Nilsson, Bo |
|
2012 |
217 |
11 |
p. 1106-1110 5 p. |
artikel |
271 |
The use of ‘real-time’ complement analysis to differentiate atypical hemolytic uraemic syndrome from other forms of thrombotic microangiopathies
|
Prohaszka, Zoltan |
|
2012 |
217 |
11 |
p. 1213- 1 p. |
artikel |
272 |
The zymogen form of the catalytic region of the complement protease, C1s, is stabilized into a form unable to interact with substrates and cofactors
|
Pike, Robert N. |
|
2012 |
217 |
11 |
p. 1213-1214 2 p. |
artikel |
273 |
Thrombin induces complement production and modulates T cell responses by dendritic cells (DCs) in kidney transplant recipients with delayed graft function (DGF)
|
Pontrelli, Paola |
|
2012 |
217 |
11 |
p. 1214- 1 p. |
artikel |
274 |
Towards a new model for the C1q – Calreticulin interaction at the phagocytic synapse
|
Touch, Sothea |
|
2012 |
217 |
11 |
p. 1214-1215 2 p. |
artikel |
275 |
Trypanosoma cruzi calreticulin inhibits the classical pathway of complement activation in Gallus gallus
|
Abello, Paula |
|
2012 |
217 |
11 |
p. 1215- 1 p. |
artikel |
276 |
Type I CD20 antibodies take over the B-cell receptor for complement-dependent cytotoxicity (CDC) of malignant B cells
|
Engelberts, Patrick J. |
|
2012 |
217 |
11 |
p. 1218- 1 p. |
artikel |
277 |
VEGF-A regulates glomerular endothelial cell expression of protective complement regulators involved in the pathogenesis of atypical haemolytic uraemic syndrome
|
Keir, Lindsay S. |
|
2012 |
217 |
11 |
p. 1215- 1 p. |
artikel |
278 |
Virion-associated complement regulator CD55 is more potent than CD46 in mediating resistance of mumps virus and VSV to neutralization
|
Johnson, John B. |
|
2012 |
217 |
11 |
p. 1215-1216 2 p. |
artikel |
279 |
Why eculizumab as treatment for EHEC-induced haemolytic uraemic syndrome?
|
Orth, Dorothea |
|
2012 |
217 |
11 |
p. 1216- 1 p. |
artikel |